Regulatory & Market Access

Regulatory & Market Access
Product Description

With the growth in pharma manufacturing capability in Asia, each manufacturer nurtures an ambition to have their own footprint in the EU market. PharmSol, with its own setups in Germany and Malta, has created a platform which provides a comprehensive, integrated and seamless market access and supply chain solution with the needed infrastructure for FDFs, APIs and Allied Products, right from the site of manufacture to the end point of the distribution chain in compliance with EU GDP guidance and on a cost-effective basis.

PharmSol Group

  • MT
  • 2015
    On CPHI since
Company types
Consultancy

PharmSol Group

  • MT
  • 2015
    On CPHI since
Company types
Consultancy

More Products from PharmSol Group (4)

  • GMP / QP Audits

    Product GMP / QP Audits

    PharmSol carries out a complete chain of audits which assures product safety and quality to clients across the globe for Finished Products, APIs, Intermediates and Key Starting Materials (KSMs). PharmSol has an in-house team of Auditors who are accredited with various certifications including APIC/CEFIC/AS...
  • Compliance Management

    Product Compliance Management

    PharmSol does not limit itself only to offering Audits, we expand our solution offerings to ensure complete Compliance at Client’s site. Towards obtaining GMP Certification from Europe or United States or WHO, PharmSol has a very effective, systematic and rationale approach in providing solution efficiently.
  • USFDA Compliance & Regulatory

    Product USFDA Compliance & Regulatory

    Preparing for a USFDA Inspection and managing the post inspection situation requires a high level of expertise and PharmSol offers a comprehensive solution in that direction.* Compliance Management * Product Development * Regulatory Support * BD Support
  • Sourcing & Supply Chain

    Product Sourcing & Supply Chain

    Finding a right source meeting your desired specifications, compliance, expectations and commercial viability is a challenge.

PharmSol Group resources (1)